HealthSquare.com

Your Prescription Drug Destination
See all our sites for your special health needs at www.HealthCentral.com

Octycine-250 Oral

Generic Name: DOCUSATE - ORAL
Pronounced: (DOCK-you-sate)

Octycine-250 Oral Interactions

Your healthcare professionals (e.g., doctor or pharmacist) may already be aware of any possible drug interactions and may be monitoring you for it. Do not start, stop or change the dosage of any medicine before checking with them first.

This drug should not be used with the following medication because very serious interactions may occur:



  • mineral oil


If you are currently using this medication, tell your doctor or pharmacist before starting docusate.

Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of:

  • aspirin
  • drugs containing phenolphthalein


This document does not contain all possible interactions. Therefore, before using this product, tell your doctor or pharmacist of all the products you use. Keep a list of all your medications with you, and share the list with your doctor and pharmacist.

Next Sectionchevron
Drug Images

chevronPrevious Section
Precautions and Side Effects



HONcode logo
We comply with the HONcode standard for health trust worthy information: verify here.
More info from:

HealthCentral.com's
Acid Reflux Site


Most Viewed

Most Searched

Latest News

  • Salmonella Outbreak Linked to Dry Dog Food
  • Arthritis may be triggered by environmental factors
  • Drug adherence does not explain diabetes race gap
  • First Beijing death linked to China virus outbreak
  • Acid problem common at diabetes diagnosis in kids
  • Learn More

    Free Newsletter: Get weekly updates, news alerts and more on Octycine-250 Oral and related health conditions.
    Sign up 


    Connect with community members who are taking Octycine-250
    Go 

    Which of these drugs are you taking?


    More info from

    HealthCentral.com's
    Acid Reflux Site




    View all conditions
    PR Newswire
    advertisement